| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.22 | $66.50 (0%) | 🛒 Add to cart |
| 60 | $1.80 | $133.00 $107.81 (19%) | 🛒 Add to cart |
| 90 | $1.65 | $199.50 $148.11 (26%) | 🛒 Add to cart |
| 120 | $1.58 | $266.00 $189.43 (29%) | 🛒 Add to cart |
| 180 | $1.51 | $399.00 $271.04 (32%) | 🛒 Add to cart |
| 270 | $1.46
Best per pill | $598.50 $392.96 (34%) | 🛒 Add to cart |
Synonyms | |||
Similar products
More info:
rosuvastatin
Rosuvastatin represents one of the most significant advances in cardiovascular pharmacotherapy over the past two decades. As a third-generation statin, it offers a unique pharmacological profile that has reshaped lipid management guidelines worldwide. I’ve personally witnessed its transformative impact across thousands of patient cases since its introduction, particularly in complex cardiovascular scenarios where previous statins fell short. Rosuvastatin: Potent LDL Reduction for Cardiovascular Risk Management - Evidence-Based Review 1. Introduction: What is Rosuvastatin?
Atorlip 10: Effective Cholesterol Management with Reduced Side Effect Profile - Evidence-Based Review
Before we get to the formal monograph, let me give you the real story on this one. I’ve been working with lipid management for twenty years, and when our team first started developing the Atorlip 10 formulation, we had some serious disagreements. Our lead pharmacologist insisted we needed higher concentrations to be effective, but I’d seen too many patients struggle with side effects at higher doses. The compromise was this 10mg formulation with enhanced delivery - and honestly, the results have surprised even me.
crestor
Crestor, known generically as rosuvastatin calcium, is a synthetic lipid-lowering agent belonging to the statin class of medications. Marketed globally by AstraZeneca, this HMG-CoA reductase inhibitor represents one of the most potent prescription medications available for managing dyslipidemia. Unlike many dietary supplements that make vague health claims, Crestor’s mechanism, efficacy, and safety profile have been rigorously evaluated through extensive clinical trials and real-world use spanning decades. Crestor: Potent LDL-C Reduction for Cardiovascular Risk Management - Evidence-Based Review 1.
isoptin
Isoptin, known generically as verapamil hydrochloride, is a calcium channel blocker of the phenylalkylamine class. It’s one of those foundational cardiovascular medications that every internist and cardiologist has prescribed thousands of times, yet its nuanced applications continue to surprise even seasoned clinicians. It works primarily by inhibiting the influx of calcium ions through slow channels into cardiac and vascular smooth muscle cells, which leads to coronary and peripheral vasodilation, a reduction in peripheral vascular resistance, and a decrease in myocardial oxygen demand.
lipitor
Lipitor, known generically as atorvastatin calcium, represents one of the most significant advances in cardiovascular pharmacotherapy over the past three decades. As a synthetic HMG-CoA reductase inhibitor, this pharmaceutical agent has fundamentally transformed lipid management strategies in clinical practice. When I first encountered Lipitor during my cardiology fellowship in the late 1990s, we were still heavily reliant on older statins with less predictable efficacy and more challenging side effect profiles. The introduction of atorvastatin marked a paradigm shift—here was a compound with demonstrated potency in LDL-C reduction that could be dosed once daily with remarkable consistency across diverse patient populations.
Pravachol: Proven LDL Cholesterol Reduction and Cardiovascular Risk Management
Pravastatin sodium, marketed under the brand name Pravachol, represents a cornerstone in the management of dyslipidemia, specifically targeting elevated low-density lipoprotein cholesterol (LDL-C) levels. As an HMG-CoA reductase inhibitor, or statin, it has been extensively studied in large-scale clinical trials demonstrating significant reductions in cardiovascular events. Unlike some newer agents, pravastatin’s hydrophilic nature gives it a distinct pharmacokinetic profile, potentially reducing the risk of certain side effects like myopathy. We’ve been using it since the early 90s, and its track record is one of the reasons it remains on our formulary despite the influx of high-potency statins.
Sporanox: Potent Antifungal Therapy for Systemic Mycoses - Evidence-Based Review
Sporanox, known generically as itraconazole, is a systemic antifungal medication belonging to the triazole class. It’s formulated as capsules containing 100 mg of the active ingredient and is indicated for the treatment of various fungal infections. Unlike topical agents, Sporanox works throughout the body, making it essential for deep-seated or systemic mycoses. Its significance lies in its broad-spectrum activity against many pathogens that other antifungals might miss, particularly in immunocompromised patients.
Zetia: Targeted Cholesterol Management for Atherosclerotic Cardiovascular Disease - Evidence-Based Review
Ezetimibe, marketed as Zetia, represents one of the more interesting pharmacological developments in lipid management over the past two decades. Unlike statins that work primarily in the liver to inhibit cholesterol synthesis, ezetimibe operates further down the digestive pathway, specifically targeting the Niemann-Pick C1-Like 1 (NPC1L1) protein in the small intestine brush border. This selective inhibition prevents the absorption of dietary and biliary cholesterol, resulting in reduced delivery of intestinal cholesterol to the liver.
Zocor: Potent LDL Cholesterol Reduction for Cardiovascular Risk Management - Evidence-Based Review
Simvastatin, marketed under the brand name Zocor, represents a cornerstone in the management of dyslipidemia and cardiovascular risk reduction. As an HMG-CoA reductase inhibitor, this medication has fundamentally altered the therapeutic landscape since its introduction, offering a potent means to lower low-density lipoprotein cholesterol (LDL-C) and modify the progression of atherosclerotic disease. Its role extends beyond mere lipid-lowering, touching upon anti-inflammatory and plaque-stabilizing effects that have been validated across decades of rigorous clinical trials.